Harpoon Therapeutics - 49 Year Dividend History | HARP
Historical dividend payout and yield for Harpoon Therapeutics (HARP) since 1971. The current TTM dividend payout for Harpoon Therapeutics (HARP) as of February 28, 2020 is $0.00. The current dividend yield for Harpoon Therapeutics as of February 28, 2020 is 0.00%.
||Medical - Drug Manufacturing
Harpoon Therapeutics Inc. is a clinical-stage immunotherapy company developing a novel class of T cell engagers which harness the power of the body's immune system to treat patients suffering from cancer and other diseases. Using its proprietary Tri-specific T cell Activating Construct(TM) platform, they are developing a pipeline of novel T cell engagers, focused on the treatment of solid tumors and hematologic malignancies. Harpoon Therapeutics Inc. is based in San Francisco, United States.